EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:3172 - bretylium
| Formula | C11H17BrN |
| Net Charge | +1 |
| Average Mass | 243.168 |
| Monoisotopic Mass | 242.05389 |
| SMILES | CC[N+](C)(C)Cc1ccccc1Br |
| InChI | InChI=1S/C11H17BrN/c1-4-13(2,3)9-10-7-5-6-8-11(10)12/h5-8H,4,9H2,1-3H3/q+1 |
| InChIKey | AAQOQKQBGPPFNS-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. |
| Applications: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bretylium (CHEBI:3172) has role adrenergic antagonist (CHEBI:37887) |
| bretylium (CHEBI:3172) has role anti-arrhythmia drug (CHEBI:38070) |
| bretylium (CHEBI:3172) has role antihypertensive agent (CHEBI:35674) |
| bretylium (CHEBI:3172) is a quaternary ammonium ion (CHEBI:35267) |
| Incoming Relation(s) |
| bretylium tosylate (CHEBI:3173) has part bretylium (CHEBI:3172) |
| IUPAC Name |
|---|
| N-(2-bromobenzyl)-N,N-dimethylethanaminium |
| Synonyms | Source |
|---|---|
| N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium | ChEBI |
| (2-bromobenzyl)ethyldimethylaminium | ChEBI |
| 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium | ChEBI |